About this trial
This study compares the effectiveness of two different volumes of buccal infiltration of Articaine for the extraction of mandibular posterior teeth. One group receives buccal infiltration of 1.8 ml of 4% Articaine and the other group receives buccal infiltration of 3.6 ml of 4% Articaine.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All healthy patients (ASA I) or patients with mild systemic disease with no functional limitations (ASA II)
Patients aged ≥ 18 years of age.
Patients requiring extraction of mandibular posterior teeth including grossly decayed tooth, grade I mobile tooth, root stumps and indicated for therapeutic reasons.
Patients not allergic to the drugs or anesthetic agents used in the surgery.
Disqualifiers
Acute infection at the extraction site.
Patients indicated for surgical extraction of teeth.
Patients already taking medications affecting pain assessment.
Pregnant patients.
Trial design
Parallel
Treatments tested in this trial
1.8 ml of 4% Articaine
Other interventionBuccal infiltration of 1.8 ml of 4% Articaine
3.6 ml of 4% Articaine
Other interventionBuccal infiltration of 3.6 ml of 4% Articaine.
Treatment groups
Trial outcomes
Primary outcomes
Intensity of pain
VAS scale is a validated scale measuring pain with possible score range from 0 (no pain) to 100 (severe pain).
Time of onset of anesthesia
It will be assessed by probing buccal and lingual soft tissue using a dental explorer every 2 minutes after infiltration using a standard digital stop clock.
Presence or absence of pain
A 100 mm Numerical rating scale assessing intraoperative pain. Possible score ranges from 0 (no pain) to 100 (worst possible pain).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.